BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3250259)

  • 1. Kidney disease in KK mice: effect of glipizide.
    Reddi AS; Velasco CA; Khan MY; Bloodworth JM; Camerini-Davalos RA
    Adv Exp Med Biol; 1988; 246():305-12. PubMed ID: 3250259
    [No Abstract]   [Full Text] [Related]  

  • 2. Kidney disease in KK mice: effect of insulin.
    Camerini-Davalos RA; Reddi AS; Wehner H; Velasco CA
    Adv Exp Med Biol; 1988; 246():333-7. PubMed ID: 3074664
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. The mesangial regions.
    Rasch R
    Diabetologia; 1979 Oct; 17(4):243-8. PubMed ID: 499683
    [No Abstract]   [Full Text] [Related]  

  • 4. Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat.
    Cooper ME; Allen TJ; Macmillan PA; Clarke BE; Jerums G; Doyle AE
    Diabetologia; 1989 May; 32(5):326-8. PubMed ID: 2546846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic microangiopathy in KK mice. VI. Effect of glycemic control on renal glycoprotein metabolism and established glomerulosclerosis.
    Reddi AS; Velasco CA; Reddy PR; Khan MY; Camerini-Davalos RA
    Exp Mol Pathol; 1990 Oct; 53(2):140-51. PubMed ID: 2148155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney disease in KK mice: effect of glyburide.
    Camerini-Davalos RA; Reddi AS
    Adv Exp Med Biol; 1988; 246():297-303. PubMed ID: 2977928
    [No Abstract]   [Full Text] [Related]  

  • 7. Kidney disease in KK mice: structural, biochemical and functional relationships.
    Reddi AS; Wehner H; Khan MY; Camerini-Davalos RA
    Adv Exp Med Biol; 1988; 246():135-45. PubMed ID: 2854953
    [No Abstract]   [Full Text] [Related]  

  • 8. Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat: are these effects specific for enalapril?
    Baba T; Sawicki PT
    Diabetologia; 1989 Nov; 32(11):829. PubMed ID: 2556309
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic and ultrastructural aspects of experimental diabetic glomerulopathy.
    Martino G; Botte L; GualĂ  L; Covello C
    J Endocrinol Invest; 1986 Apr; 9(2):87-95. PubMed ID: 3011887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic glomerulosclerosis in KK mice and its prevention by glyburide and pyridinolcarbamate.
    Camerini-Davalos RA; Reddi AS; Ehrenreich TH; Strugatz LH; Oppermann W
    Adv Exp Med Biol; 1979; 119():387-400. PubMed ID: 115232
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of bromhexine on experimentally induced diabetic nephropathy.
    Luscombe M; Poulding JM; Amer B; Clamp JR; Hartog M; Shelley JH; Tribe CR
    Br J Exp Pathol; 1983 Aug; 64(4):462-5. PubMed ID: 6615713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence of changes in KK mouse nephropathy.
    Wehner H
    Adv Exp Med Biol; 1988; 246():147-56. PubMed ID: 3250252
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of Linagliptin on Structural Changes in the Kidney in Experimental Type 2 Diabetes Mellitus.
    Gavrilova YS; Bgatova NP; Klimontov VV; Ischenko IY; Michurina SV; Myakina NE; Zavyalov EL
    Bull Exp Biol Med; 2016 Aug; 161(4):501-4. PubMed ID: 27591880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of sulfated carbohydrate from the glomerular podocyte as a cause of albuminuria in experimental diabetic rats: ultrastructural histochemical study.
    Ina K; Kitamura H; Nakamura M; Ono J; Takaki R
    J Diabet Complications; 1991; 5(2-3):173-5. PubMed ID: 1770036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced reversal of early diabetic microangiopathy.
    Camerini-Davalos RA; Velasco C; Glasser M; Bloodworth JM
    N Engl J Med; 1983 Dec; 309(25):1551-6. PubMed ID: 6656850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of the glomerular basement membrane in sucrose-fed and streptozotocin-diabetic rats.
    Taylor SA; Price RG; Kang SS; Yudkin J
    Diabetologia; 1980 Oct; 19(4):364-72. PubMed ID: 6448759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance in patients with insulin independent diabetes mellitus: partial amelioration by the sulfonylurea glipizide.
    Lebovitz H; Feinglos MN
    Adv Exp Med Biol; 1979; 119():371-9. PubMed ID: 495293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfonylurea-induced decrease of muscle capillary basement membrane thickness in diabetes.
    Camerini-Davalos RA; Velasco CA; Glasser M; Bloodworth JM
    Diabetes Res Clin Pract; 1988 Jul; 5(2):113-23. PubMed ID: 3046878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of heparin and aminoguanidine on glomerular basement membrane thickening in diabetic rats.
    Oturai PS; Rasch R; Hasselager E; Johansen PB; Yokoyama H; Thomsen MK; Myrup B; Kofoed-Enevoldsen A; Deckert T
    APMIS; 1996 Apr; 104(4):259-64. PubMed ID: 8645464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro and in vivo inhibition of protein glycosylation and diabetic vascular basement membrane thickening by pyridoxal-5'-phosphate.
    Hayakawa M; Shibata M
    J Nutr Sci Vitaminol (Tokyo); 1991 Apr; 37(2):149-59. PubMed ID: 1919802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.